ArticleBritish journal of pharmacology2019

Loganetin protects against rhabdomyolysis-induced acute kidney injury by modulating the toll-like receptor 4 signalling pathway.

Jie Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.